# | Title | Journal | Year | Citations |
---|
1 | Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium | Clinical Infectious Diseases | 2020 | 1,429 |
2 | Gene cassettes and cassette arrays in mobile resistance integrons | FEMS Microbiology Reviews | 2009 | 555 |
3 | Echinocandin Antifungal Drugs in Fungal Infections | Drugs | 2011 | 324 |
4 | Sequence-Based Identification of Aspergillus, Fusarium , and Mucorales Species in the Clinical Mycology Laboratory: Where Are We and Where Should We Go from Here? | Journal of Clinical Microbiology | 2009 | 299 |
5 | Analysis of antibiotic resistance regions in Gram-negative bacteria | FEMS Microbiology Reviews | 2011 | 290 |
6 | Development and Clinical Application of a Panfungal PCR Assay To Detect and Identify Fungal DNA in Tissue Specimens | Journal of Clinical Microbiology | 2007 | 289 |
7 | International Society of Human and Animal Mycology (ISHAM)-ITS reference DNA barcoding database—the quality controlled standard tool for routine identification of human and animal pathogenic fungi | Medical Mycology | 2015 | 252 |
8 | Unambiguous identification of fungi: where do we stand and how accurate and precise is fungal DNA barcoding? | IMA Fungus | 2020 | 232 |
9 | Scedosporium and Lomentospora: an updated overview of underrated opportunists | Medical Mycology | 2018 | 186 |
10 | Genome Variation in Cryptococcus gattii, an Emerging Pathogen of Immunocompetent Hosts | MBio | 2011 | 182 |
11 | Not Just Little Adults: Candidemia Epidemiology, Molecular Characterization, and Antifungal Susceptibility in Neonatal and Pediatric Patients | Pediatrics | 2009 | 171 |
12 | Clinical Manifestations of Cryptococcus gattii Infection: Determinants of Neurological Sequelae and Death | Clinical Infectious Diseases | 2012 | 171 |
13 | Multicenter Study of Posaconazole Therapeutic Drug Monitoring: Exposure-Response Relationship and Factors Affecting Concentration | Antimicrobial Agents and Chemotherapy | 2012 | 164 |
14 | Phospholipase Activity in Cryptococcus neoformans: A New Virulence Factor? | Journal of Infectious Diseases | 1997 | 156 |
15 | Emergence of a Plasmid-Encoded Resistance-Nodulation-Division Efflux Pump Conferring Resistance to Multiple Drugs, Including Tigecycline, in Klebsiella pneumoniae | MBio | 2020 | 153 |
16 | Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death | Journal of Antimicrobial Chemotherapy | 2010 | 148 |
17 | Sequence Analysis of In Vivo Defective Interfering-Like RNA of Influenza A H1N1 Pandemic Virus | Journal of Virology | 2013 | 144 |
18 | Invasive infections due to filamentous fungi other than Aspergillus: epidemiology and determinants of mortality | Clinical Microbiology and Infection | 2015 | 129 |
19 | Defining breakthrough invasive fungal infection–Position paper of the mycoses study group education and research consortium and the European Confederation of Medical Mycology | Mycoses | 2019 | 129 |
20 | Horizontal Gene Transfer in a Polyclonal Outbreak of Carbapenem-Resistant Acinetobacter baumannii | Journal of Clinical Microbiology | 2007 | 128 |
21 | Concordance of clinical and environmental isolates of Cryptococcus neoformans var. gattii by random amplification of polymorphic DNA analysis and PCR fingerprinting | Journal of Clinical Microbiology | 1996 | 128 |
22 | A review of nucleic acid-based diagnostic tests for systemic mycoses with an emphasis on polymerase chain reaction-based assays | Medical Mycology | 2002 | 116 |
23 | Eicosapentaenoic acid in cystic fibrosis: evidence of a pathogenetic role for leukotriene B4 | Lancet, The | 1993 | 115 |
24 | MALDI-TOF MS Enables the Rapid Identification of the Major Molecular Types within the Cryptococcus neoformans/C. gattii Species Complex | PLoS ONE | 2012 | 113 |
25 | Identification of extracellular phospholipase B, lysophospholipase, and acyltransferase produced by Cryptococcus neoformans | Infection and Immunity | 1997 | 108 |
26 | Antifungal Therapy and Management of Complications of Cryptococcosis due to Cryptococcus gattii | Clinical Infectious Diseases | 2013 | 106 |
27 | Recombination in IS 26 and Tn 2 in the Evolution of Multiresistance Regions Carrying bla CTX-M-15 on Conjugative IncF Plasmids from Escherichia coli | Antimicrobial Agents and Chemotherapy | 2011 | 105 |
28 | Tracing Genetic Exchange and Biogeography of Cryptococcus neoformans var. grubii at the Global Population Level | Genetics | 2017 | 105 |
29 | Enhancement of the Influenza A Hemagglutinin (HA)-Mediated Cell-Cell Fusion and Virus Entry by the Viral Neuraminidase (NA) | PLoS ONE | 2009 | 101 |
30 | Proposal for assignment of allele numbers for mobile colistin resistance (mcr) genes | Journal of Antimicrobial Chemotherapy | 2018 | 101 |
31 | Breakthrough invasive fungal infections: Who is at risk? | Mycoses | 2020 | 94 |
32 | Purification and characterization of secretory phospholipase B, lysophospholipase and lysophospholipase/transacylase from a virulent strain of the pathogenic fungus Cryptococcus neoformans | Biochemical Journal | 2000 | 92 |
33 | Dominance of bla CTX-M within an Australian Extended-Spectrum β-Lactamase Gene Pool | Antimicrobial Agents and Chemotherapy | 2008 | 87 |
34 | Natural environmental sources of Cryptococcus neoformans var. gattii | Journal of Clinical Microbiology | 1996 | 86 |
35 | Antifungal therapy in invasive fungal infections | Current Opinion in Pharmacology | 2010 | 85 |
36 | Multiplex Tandem PCR: a Novel Platform for Rapid Detection and Identification of Fungal Pathogens from Blood Culture Specimens | Journal of Clinical Microbiology | 2008 | 83 |
37 | Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes | Hepatology | 2016 | 83 |
38 | Mucormycosis in Australia: contemporary epidemiology and outcomes | Clinical Microbiology and Infection | 2016 | 83 |
39 | Geographically Structured Populations of Cryptococcus neoformans Variety grubii in Asia Correlate with HIV Status and Show a Clonal Population Structure | PLoS ONE | 2013 | 83 |
40 | Molecular techniques for pathogen identification and fungus detection in the environment | IMA Fungus | 2011 | 81 |
41 | Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation with ISHAM and ASM | Lancet Infectious Diseases, The | 2021 | 80 |
42 | Characterization of the Natural Population of Bartonella henselae by Multilocus Sequence Typing | Journal of Clinical Microbiology | 2003 | 79 |
43 | Multiplex PCR for screening of integrons in bacterial lysates | Journal of Microbiological Methods | 2005 | 79 |
44 | Candidaemia with uncommon Candida species: predisposing factors, outcome, antifungal susceptibility, and implications for management | Clinical Microbiology and Infection | 2009 | 79 |
45 | In Vitro Susceptibility of the Yeast Pathogen Cryptococcus to Fluconazole and Other Azoles Varies with Molecular Genotype | Journal of Clinical Microbiology | 2010 | 76 |
46 | Accurate and Practical Identification of 20 Fusarium Species by Seven-Locus Sequence Analysis and Reverse Line Blot Hybridization, and an In Vitro Antifungal Susceptibility Study | Journal of Clinical Microbiology | 2011 | 75 |
47 | Coronavirus Disease 2019–Associated Invasive Fungal Infection | Open Forum Infectious Diseases | 2021 | 75 |
48 | Detection of Occult Scedosporium Species in Respiratory Tract Specimens from Patients with Cystic Fibrosis by Use of Selective Media | Journal of Clinical Microbiology | 2010 | 74 |
49 | The Crz1/Sp1 Transcription Factor of Cryptococcus neoformans Is Activated by Calcineurin and Regulates Cell Wall Integrity | PLoS ONE | 2012 | 73 |
50 | Clonality and α-a Recombination in the Australian Cryptococcus gattii VGII Population - An Emerging Outbreak in Australia | PLoS ONE | 2011 | 71 |